does midi prescribe glp 1 glp-1 The FDA has approved oral Wegovy—a daily pill option for Who Can Prescribe GLP-1 |
Description
PlexusDx helps patients navigate these interactions with personalized compounded therapy
The Global GLP-1 Receptor Agonists Obesity Drugs Market was valued at USD 9.96 Billion in 2024 and is expected to reach USD 33.12 Billion by 2032, growing at a CAGR of 16.20% (2025-2032).
Wegovy, Zepbound, Saxenda, and other GLP-1 or GIP medications are needlessly out of reach for many Americans.
doi: 10.3390/nu15041013
PMID: 38465169
PlexusDx helps patients navigate semaglutide therapy after cholecystectomy with personalized dosing and genetic insights
